DOD Biotech (Thailand) Probability of Future Stock Price Finishing Over 384.42
| DOD Stock | 2.18 0.04 1.87% |
DOD |
DOD Biotech Target Price Odds to finish over 384.42
The tendency of DOD Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 384.42 or more in 90 days |
| 2.18 | 90 days | 384.42 | close to zero percent |
Based on a normal probability distribution, the odds of DOD Biotech to move over 384.42 or more in 90 days from now is close to zero percent (This DOD Biotech Public probability density function shows the probability of DOD Stock to fall within a particular range of prices over 90 days) . Probability of DOD Biotech Public price to stay between its current price of 2.18 and 384.42 at the end of the 90-day period is about 72.45 .
Assuming the 90 days trading horizon the stock has the beta coefficient of 1.16 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, DOD Biotech will likely underperform. Additionally DOD Biotech Public has an alpha of 0.304, implying that it can generate a 0.3 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). DOD Biotech Price Density |
| Price |
Predictive Modules for DOD Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as DOD Biotech Public. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.DOD Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. DOD Biotech is not an exception. The market had few large corrections towards the DOD Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold DOD Biotech Public, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of DOD Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.30 | |
β | Beta against Dow Jones | 1.16 | |
σ | Overall volatility | 0.52 | |
Ir | Information ratio | 0.07 |
DOD Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of DOD Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for DOD Biotech Public can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| DOD Biotech Public is way too risky over 90 days horizon | |
| DOD Biotech Public appears to be risky and price may revert if volatility continues | |
| About 48.0% of the company shares are held by company insiders |
DOD Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of DOD Stock often depends not only on the future outlook of the current and potential DOD Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. DOD Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 410 M |
DOD Biotech Technical Analysis
DOD Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. DOD Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of DOD Biotech Public. In general, you should focus on analyzing DOD Stock price patterns and their correlations with different microeconomic environments and drivers.
DOD Biotech Predictive Forecast Models
DOD Biotech's time-series forecasting models is one of many DOD Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary DOD Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about DOD Biotech Public
Checking the ongoing alerts about DOD Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for DOD Biotech Public help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| DOD Biotech Public is way too risky over 90 days horizon | |
| DOD Biotech Public appears to be risky and price may revert if volatility continues | |
| About 48.0% of the company shares are held by company insiders |
Other Information on Investing in DOD Stock
DOD Biotech financial ratios help investors to determine whether DOD Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DOD with respect to the benefits of owning DOD Biotech security.